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Summary Synovial sarcoma is rare in the head and neck, especially in the oral and
maxillofacial region. We report a case of synovial sarcoma of the mandible in a 42-
year-old man. The patient was referred with recurrent diffuse swelling in the right
buccal area and underwent regional resection of the right mandibular bone with
construction. He has been alive and well with no evidence of disease for seven years
since final surgery. The histological features are described and diagnostic problems
discussed.c 2004 Elsevier Ltd. All rights reserved.
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Synovial sarcoma (SS) is a rare malignant neo-
plasm that arises most commonly in joint capsules
and articular tendons, but relationship to the syno-
vium is not always obvious. The most common sites
involved in the head and neck include the hypo-741-9409/$ - see front matter c 2004 Elsevier Ltd. All rights rese
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otmail.com (C. Koga).pharynx, postpharyngeal region and the parapha-
ryngeal space.1–5
We describe an extremely rare case of SS in the
mandibular bone, and discuss the related diagnos-
tic challenges of the case.Case report
A 42-year-old man was referred with suspected
recurrence of hemangiopericytoma in the right
mandibular bone to our hospital in April 1997. On
initial examination there was diffuse swelling inrved.
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shaped mass, measuring 3.5 · 3.5 cm, was palpable
extraorally with swelling and appeared with normal
color in the right buccal mucosa. There was no par-
esthesia of the right inferior alveolar nerve.
A panoramic radiograph showed a scalloped-
bordered radius lucent in the right mandibular body
extending from the canine to the molar region. A
computed tomography scanning revealed a mass
of 5.0 cm in diameter destroying in the right man-
dibular bone. In May 1997, a second embolization,
plus segmental resection of the right mandible,
including the overlying buccal soft tissues, was per-
formed using a DP flap and A-O plate. There has
been no evidence of recurrence or distant metasta-
sis for seven years following the final surgical
treatment.Pathology
Gross
The tumor presented as a yellowish-white lobu-
lated solid mass, measuring 3.0 · 3.0 cm, andFigure 1 Microphotograph of SS in the mandibular bone. So
section, 50). A mixture of spindle-shaped cells and round, v
cell borders. There is remarkable cellular atypia, but only s
section, 200).showed a necrotic lesion in the central part of
the cut surface. It was mobile from the skin subcu-
taneous connective tissue, while adhesion to the
mandibular bone was noted.Microscopy
The tumor consisted of an unencapsulated,
solid, monotonous proliferation of small spindle-
shaped or ovoid neoplastic cells with pale, eosino-
philic cytoplasm and an indistinct border. There
was infiltration into the surrounding soft tissues,
and destruction of the buccal cortical plate, plus
infiltration of the medullary bone (Fig. 1a). The
neoplastic cells were atypical, with frequent mito-
tic figures; however, nuclear pleomorphism was
not valid (Fig. 1b). Extensive ‘‘staghorn’’ vascular
pattern were observed as well as necrotic foci
caused by embolization in some areas. The overly-
ing squamous epithelium was unaffected.
Immunohistochemical staining was carried out
with the avidin–biotin method. The antibodies
used, their sources, and the staining results of this
case are listed in Table 1.lid, cellular mass infiltrates the mandibular bone (a; HE
esicular nuclei, pale eosinophilic cytoplasm and indistinct
light pleomorphism, one mitotic figure is evident (b; HE
Table 1 Results of immunohistochemical staining, antibodies used, and their sources
Antibody Immunoreaction Source
CD34 ++ Novocastra, UK
Cytokeratin + DAKO, Denmark
EMA + (partial) DAKO
S-100 Protein  DAKO
SMA  DAKO
CD68  DAKO
Factor VIII  DAKO
a ACT  DAKO
NSE  Nichirei, Japan
Desmin  DAKO
Vimentin  DAKO
Muscle Actin, HHF35  DAKO
Abbreviations: EMA, epithelial membrene antigen; SMA, smooth muscle actin; NSE, neuron specific enolase. ++: strong positive, +:
positive, : negative.
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A few cases in the tongue have been described in
the literature.6,7 It sometimes appears in locations
unrelated to synovium, thus, its origin remains un-
known. Also intraosseous location of SS is possible.8
Variants of SS are subclassified into three
groups: (i) monophasic epithelial type; (ii) mono-
phasic spindle cell type; and (iii) biphasic type with
distinct epithelial and spindle cell components.
Regardless of the subtype, the conventional clues
and immunohistochemical evidence of the epithe-
lial element is characteristic of SS9,10 and has led
to the consensus that this tumor should be re-
garded as a carcinosarcoma of soft tissue origin.11
In addition to the three subtypes, Enzinger and
Weiss2 have described a ‘‘poorly differentiated’’
type of SS compromising a relatively high percent-
age (20%) of their cases of whole SS, which shows
more aggressive behavior and shares histological
feature similar to those seen in the present case.
Prominent ‘‘staghorn’’ vascular pattern may cause
a serious problem in distinction from hemangioper-
icytoma, and, actually, the initial diagnosis was
malignant hemangiopericytoma also in our case.
Staghorn vessels appear in various other mesenchy-
mal tumors, including SS, leiomyosarcoma, malig-
nant peripheral nerve sheath tumor, malignant
fibrous histiocytoma, solitary fibrous tumor and
others.12 They2 further noted that this pattern is
frequently encountered in poorly differentiated SS.
CD34 is a general marker for hematopoietic stem
cells and endothelial cells. However, CD34 reactiv-
ity has been demonstrated in various non-vascular
tumors, such as leiomyosarcoma and epithelioid
sarcoma13 as well as lipomatous, benign nerve
sheath and gastrointestinal stromal tumors.14–16CD34 thus may be seen in a wide range of neoplas-
tic mesenchymal or poorly differentiated sarcoma-
tous cells.
Previously, SS had not been known to show CD34
reactivity3,4 until the report by Pelmus et al.17 was
published. In their series, six cases out of mono-
phasic fibrous SS were positive for CD34, although
all of 13 poorly differentiated SSs were negative.
However, we believe there remains the possibility
that poorly differentiated SS would show CD34
immunoreactivity and this case could be the first
case of CD34 positive poorly differentiated SS.
From this perspective, epithelioid sarcoma,
which shows immunoreactivity for cytokeratin,
EMA and CD34,18 is the most important differential
diagnosis for the present case. However, epitheli-
oid sarcoma is not listed among the soft tissue tu-
mors with a hemangiopericytoma-like vascular
pattern. It is of interest that cytokeratin expression
is recognized in epithelioid vascular neoplasm19
and, while some angiomatid carcinomas of the thy-
roid gland are immunoreactive for CD34, some sar-
comatoid carcinomas without the angiomatoid
feature are negative for CD34.20 This case did not
show distinctive angiomatoid features, other than
hemangiopericytoma-like pattern, nor immunore-
activity for myogenic or neurogenic marker panels.
Jaw malignancies may also have odontogenic or
salivary gland origins. No characteristic remnants
of odontogenic epithelium or ectopic gland were
evident in this case. A thorough histopathlogic
examination failed to reveal any evidence of dys-
plastic change in the overlying mucosa and, thus,
sarcomatoid spindle cell sarcoma was ruled out.
Exactly detection of characteristic t(X;
18)(p11.2;q11.2) is a powerful diagnostic tool and
this translocation is found in more than 90% of
48 C. Koga et al.SSs, but exceptional cases may exist. Genetic trial
was made for present case too, but failed. The
material revealed prominent necrosis probably
due to embolization.
Considering the combined morphologic and
immunohistochemical features, we believe that
the tumor described herein is most likely SS. Fur-
ther, we believe that this tumor originated from
a primitive mesenchymal precursory cell in the
mandibular bone.
Wide surgical resection is the primary treatment
option for SS. Long term follow-up is necessary, be-
cause the prognosis is often poor and many patients
develop lung metastases. If the tumor can be surgi-
cally removed with an adequate margin, adjunctive
radiation or chemotherapy is not always required.References
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